Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark this as readOnly/idempotent, and the description adds substantial behavioral detail: internal multi-endpoint cascade, graceful degradation when GLEIF/OpenFIGI is unavailable, explicit `unresolved` reporting, and ambiguity handling via `figi_candidates`. This goes well beyond the annotations and gives the agent accurate expectations for edge cases.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but it is organized with clear sections and dense with necessary nuance for a multi-source resolver. It front-loads the core purpose and usage rule, while later details cover edge cases; still, it could be slightly more compressed without losing value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description sufficiently characterizes return behavior: which identifiers are produced for each type, source labeling, unresolved fields, candidate lists for ambiguous matches, and RxNorm citations. Given the tool's complexity, this is a complete enough contract for an agent to select and call it correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already covers both parameters fully, and the description adds significant complementary guidance: accepted value forms per type, ticker/CIK/ISIN/name options, and a crucial caution about passing only the issuer name rather than the full noun phrase. This materially improves correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user queries and immediately states the core purpose: resolve a user-spoken name to canonical/official identifiers. It clearly specifies supported entity types and the identifier domains (CIK, ticker, LEI, FIGI, RxCUI), making the tool's scope unambiguous and distinct from general lookup or profile tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'Use FIRST whenever you have a name but need an ID' and gives supported types plus examples of valid input forms. However, it does not name sibling alternatives or describe when one of those should be preferred over resolve_entity, so the routing guidance is strong but not fully comparative.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

Several tools have heavily overlapping purposes: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-identical, and the five polymarket_* tools (arbitrage, edges, edge_tracker, fill_risk, kalshi_spread) all target prediction-market opportunities. The memory tools (remember/recall/forget) are distinct, as are subscriptions, but the routing and Polymarket clusters create real misselection risk.

Naming Consistency3/5

All names are snake_case, but the pattern is mixed: some are verb_noun (ask_pipeworx, compare_entities, discover_tools, resolve_entity), some are noun_verb or adjective_noun (bet_research, entity_profile, pipeworx_trending, recent_changes), and some are bare nouns/verbs (lookup, query, recall, relatedness). The 'polymarket_*' and 'ask_pipeworx*' families are consistent internally, but the overall set lacks a uniform verb-first convention.

Tool Count2/5

With 34 tools, the server is heavily over-scoped for a server named 'Conceptnet' — the vast majority of tools belong to a separate Pipeworx data-access product, not a semantic-network API. While each tool has a use, the count feels bloated and the server name misrepresents the actual surface.

Completeness4/5

The ConceptNet portion is complete (lookup, query, relatedness cover graph traversal). The Pipeworx portion is also fairly complete: universal router, grounded mode, deep research, entity profiles, comparisons, claim validation, subscription lifecycle, memory, and feedback. Minor gaps exist (e.g., no direct SEC filing fetch without going through ask_pipeworx), but the meta-tools mostly fill them.